Sunshine Biopharma, Inc.
SBFMNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $314.02K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.21$23.20
- Volume (live)
- -
- Avg. volume (3M)
- 10.45M
Sunshine Biopharma (SBFM) Stock Price & Financial Analysis
Sunshine Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.21 - $0.23 |
|---|---|
| 52-Week High | $23.20 |
| 52-Week Low | $0.21 |
| Open | $0.22 |
| Volume (last close) | 876.88K |
| Average Volume (3M) | 10.45M |
| Revenue (TTM) | 35.35M |
|---|---|
| Net Income (TTM) | -5.83M |
| Free Cash Flow (TTM) | -5.39M |
| EPS (TTM) | −$8.34 |
| Profit Margin | -16.50% |
| Operating Margin | -14.71% |
| Return on Equity (ROE) | -21.18% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 314.02K |
|---|---|
| Shares Outstanding | 1.37M |
| Price to Sales (P/S) | 0.01 |
| Price to Book (P/B) | 0.01 |
| EV/EBITDA | 2.36 |
| 50-Day MA | $0.95 |
|---|---|
| 200-Day MA | $3.84 |
| 1-Year Change | −89.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Sunshine Biopharma at a Glance
As of the Oct 16, 2026 close, Sunshine Biopharma (SBFM) has a market capitalization of $314.02K. The stock trades at 0.0× sales. Over the trailing twelve months it lost $5.83M on revenue of $35.35M and burned $5.39M of free cash flow. Revenue fell 2.7% year over year.
As of its latest reported balance sheet, it holds $13.75M in cash and securities against $678.34K of debt, a net cash position of $13.07M.
Sunshine Biopharma does not currently pay a dividend.
The share price is down 89.0% over the past year. At $0.22 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.21 to $23.20, below its 200-day moving average of $3.84.
Frequently Asked Questions About Sunshine Biopharma
What is the current stock price for SBFM?
As of the Oct 16, 2026 close, SBFM stock trades at $0.22. The 52-week range is $0.21–$23.20, with a day range of $0.20–$0.23.
What is the P/E ratio for SBFM?
The P/E ratio (Price-to-Earnings) for SBFM is shown in the Key Statistics section. This valuation metric helps compare Sunshine Biopharma, Inc. to industry peers.
Does SBFM pay dividends?
Sunshine Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SBFM?
Analyst ratings and recommendations for SBFM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SBFM?
As of the Oct 16, 2026 close, Sunshine Biopharma's market capitalization is $302,828.863, classifying it as a micro-cap company. Sunshine Biopharma operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.